Cedric Francois

Companies

• Apellis Pharmaceuticals, Inc.Board member Nov 8, 2017 to now¹
• Apellis Pharmaceuticals, Inc.Chief executive officer Nov 8, 2017 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APApellis Pharmaceuticals, Inc.0 shares²May 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 14, 2026Returned to company 195,952 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 97,997 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 36,047 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 20,862 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 195,952 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Granted 195,952 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 97,976 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Granted 97,976 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 87,108 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Granted 87,108 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 143,750 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Granted 143,750 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026U 234,411 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026U 300,000 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026U 472,065 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026U 372,815 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026U 425,968 shares of Apellis Pharmaceuticals, Inc.²
• Mar 11, 2026Gift 64,869 shares of Apellis Pharmaceuticals, Inc.³
• Mar 11, 2026Gift 64,869 shares of Apellis Pharmaceuticals, Inc.³
• Feb 3, 2026Exercised options 8,840 shares at $3.76 of Apellis Pharmaceuticals, Inc.⁴
• Jan 28, 2026Granted 195,952 shares of Apellis Pharmaceuticals, Inc.⁵
• Jan 22, 2026Sold 27,192 shares at $21.77 of Apellis Pharmaceuticals, Inc.⁶
• Jan 20, 2026Sold 8,182 shares at $19.79 of Apellis Pharmaceuticals, Inc.⁷
• Jan 13, 2026Sold 10,186 shares at $22.19 of Apellis Pharmaceuticals, Inc.⁸
• Aug 28, 2025Sold 49,963 shares at $28.39 of Apellis Pharmaceuticals, Inc.⁹